This fractionation approach enables separation of TIC (Epcam+CD44-CD49fHi), which display superior ability to regenerate prostate grafts in vivo from BC (Epcam+CD44+CD49fHi), which are more proliferative in sphere-forming assays in vitro. This evidence concerns the gene CD44 and breast cancer.